McLaughlin, R. A., Jonker, D. J., Karanicolas, P. J., Ko, Y., Welch, S., Renouf, D. J., Bertens, K., Moulton, C., Raphael, M. J., Jayaraman, S., Ye, X. Y., Zhang, A., Kim, T., Khalili, K., Duan, K., Fischer, S., O'Kane, G. M., Dodd, A., Gallinger, S., Knox, J. J. (2025). NeoPancONE: GATA6 expression as a predictor of benefit to peri-operative modified FOLFIRINOX in resectable pancreatic adenocarcinoma (r-PDAC): A multicentre phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4011